Providence Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Providence Capital Advisors's AMGN Position: Q4 2024 in Review
Providence Capital Advisors sold out of Amgen (AMGN) in Q4 2024, closing a stake of 3 shares — an estimated $967 sold.
Providence Capital Advisors first reported a position in AMGN in Q2 2019 and held it in 13 quarters. The position peaked at $81K in Q3 2021. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.
- Providence Capital Advisors reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
- Providence Capital Advisors sold 3 Amgen shares in Q4 2024, an estimated $967.
- Providence Capital Advisors first reported a position in Amgen in Q2 2019 and held it in 13 quarters.
- Providence Capital Advisors's Amgen position peaked at $81K in Q3 2021.
- 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.
Based on Providence Capital Advisors's 13F filing for Q4 2024, filed 12 Feb 2025.